

Nucleate RI | Inside: Women Leading Life Sciences
Event Overview:
Join Nucleate Rhode Island for a panel on women leaders in Biotech. Ever wonder what kinds of leadership roles are out there for you as a woman in STEM? And how does one work towards these roles using their experiences behind a lab bench? Learn from leaders across different sectors of industry as they share their career journeys and discuss the dynamic landscape for women leaders in Biotech.
Special thanks to our regional sponsors, RILSH, Ocean State Labs and CIC Providence, for making this event possible.
This event will take place at Ocean State Labs, 150 Richmond Street, Providence, RI.
Panelists:
Meet the Speakers & Panelists
Sophie Chapelle is the CEO of Pensive Health and has more than 30 years of experience building therapeutics, diagnostics and medical device businesses. She previously led corporate development at Sherlock Biosciences, a CRISPR-based diagnostics company, and was Chief Commercial Officer at Scipher Medicine. Earlier, she held business development roles at Pfizer. She is also a founding member of BelCham’s Life Sciences Chapter, where she advises on fundraising and non-dilutive funding in the US market.
Dr. Cheryl Vaughan leads innovation training programs at Harvard Catalyst, Harvard’s center for clinical and translational science, which helps researchers across Harvard and its affiliated hospitals turn discoveries into better health. She previously directed the Master’s in Biotechnology program at Harvard Extension School and built the Skills Development Center at the Boston Biomedical Innovation Center. In 2023 she founded the Rhode Island chapter of the Association for Women in Science, which creates a supportive community for women in STEM across the state.
Dr. Danya Lavin leads Ocean State Labs, Rhode Island’s life sciences incubator and tonight’s host. It is run by Portal Innovations, a venture firm that gives early-stage biotech and medtech startups funding and fully equipped lab space. She is a biomedical engineer who earned her PhD at Brown, where her research focused on drug delivery and biomaterials. She was a Principal Scientist at Semma Therapeutics, and after Vertex Pharmaceuticals acquired Semma she built and led a translational research group there. She also serves on the advisory board of Nucleate Rhode Island.
About the Host:
Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.xyz for more information, and visit https://nucleate.xyz/privacy-policy/ to read our privacy policy.
We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!
Platinum: Eli Lilly and Company, Genentech, Alnylam Pharmaceuticals, MilliporeSigma
Philanthropic Support: Lyda Hill Philanthropies
Preferred Partners: Pillar VC, Amino Collective, Excedr, Mercury, Brex, Fedsprout
In-Kind Support: AcademicLabs, Lens.org, SynBioBeta